Paper21813640
Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor.
Hashimoto H and 5 others. J Biol Chem, 2011. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor. Papers, record 21813640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21813640
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of β-amyloid precursor protein-derived inhibitor.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Matrix Metalloproteinase 2 | Major topic |
| Matrix Metalloproteinase Inhibitors | Major topic |
| Proteins | Major topic |
| Amino Acid Sequence | |
| Catalytic Domain | |
| Crystallography, X-Ray | |
| Humans | |
| Models, Molecular | |
| Molecular Sequence Data | |
| Mutant Proteins | |
| Protein Binding | |
| Protein Structure, Secondary |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19551841 | Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells. | Int J Cancer | 2010 | https://conductscience.org/library/papers/19551841 | PubMed |
| 2 | 9724659 | Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. | EMBO J | 1998 | https://conductscience.org/library/papers/9724659 | PubMed |
| 3 | 12032297 | Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12032297 | PubMed |
| 4 | 12586836 | Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12586836 | PubMed |
| 5 | 27754618 | Processing of X-ray diffraction data collected in oscillation mode. | Methods Enzymol | 1997 | https://conductscience.org/library/papers/27754618 | PubMed |
| 6 | 18955490 | Identification of amino acid residues of matrix metalloproteinase-7 essential for binding to cholesterol sulfate. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18955490 | PubMed |
| 7 | 8479521 | A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. | Nature | 1993 | https://conductscience.org/library/papers/8479521 | PubMed |
| 8 | 9288970 | Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. | Nature | 1997 | https://conductscience.org/library/papers/9288970 | PubMed |
| 9 | 11278347 | The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11278347 | PubMed |
| 10 | 17991754 | Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism. | J Biol Chem | 2008 | https://conductscience.org/library/papers/17991754 | PubMed |
| 11 | 9390552 | ECM and cell surface proteolysis: regulating cellular ecology. | Cell | 1997 | https://conductscience.org/library/papers/9390552 | PubMed |
| 12 | 1691865 | Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. | Science | 1990 | https://conductscience.org/library/papers/1691865 | PubMed |
| 13 | 11990853 | New functions for the matrix metalloproteinases in cancer progression. | Nat Rev Cancer | 2002 | https://conductscience.org/library/papers/11990853 | PubMed |
| 14 | 1279136 | Association and release of the amyloid protein precursor of Alzheimer's disease from chick brain extracellular matrix. | J Neurosci | 1992 | https://conductscience.org/library/papers/1279136 | PubMed |
| 15 | 8137810 | The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. | EMBO J | 1994 | https://conductscience.org/library/papers/8137810 | PubMed |
| 16 | 9249047 | 1.8-A crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile. | Eur J Biochem | 1997 | https://conductscience.org/library/papers/9249047 | PubMed |
| 17 | 16498445 | Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16498445 | PubMed |
| 18 | 16405877 | Structure and function of matrix metalloproteinases and TIMPs. | Cardiovasc Res | 2006 | https://conductscience.org/library/papers/16405877 | PubMed |
| 19 | 10818225 | The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. | FEBS Lett | 2000 | https://conductscience.org/library/papers/10818225 | PubMed |
| 20 | 2881207 | The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. | Nature | 1987 | https://conductscience.org/library/papers/2881207 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41478668 | Kidney-specific delivery of a matrix metalloproteinase-2 inhibitory peptide fused to elastin-like polypeptide reduces proteinuria and renal fibrosis in a model of salt-sensitive hypertension. | J Pharmacol Exp Ther | 2025 | https://conductscience.org/library/papers/41478668 | PubMed |
| 41069169 | Recent advances in the design and development of small-molecule MMP-2 inhibitors. | Future Med Chem | 2025 | https://conductscience.org/library/papers/41069169 | PubMed |
| 40265458 | Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets. | BioTech (Basel) | 2025 | https://conductscience.org/library/papers/40265458 | PubMed |
| 40164643 | A multifaceted examination of the action of PDE4 inhibitor rolipram on MMP2/9 reveals therapeutic implications. | Sci Rep | 2025 | https://conductscience.org/library/papers/40164643 | PubMed |
| 39023545 | Unveiling esophageal cancer treatment mechanisms: network pharmacology and molecular docking of Physcion. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39023545 | PubMed |
| 36997589 | Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14. | Sci Rep | 2023 | https://conductscience.org/library/papers/36997589 | PubMed |
| 35013344 | Harnessing protein folding neural networks for peptide-protein docking. | Nat Commun | 2022 | https://conductscience.org/library/papers/35013344 | PubMed |
| 33373399 | Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library. | PLoS One | 2020 | https://conductscience.org/library/papers/33373399 | PubMed |
| 28299742 | Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors. | Methods Mol Biol | 2017 | https://conductscience.org/library/papers/28299742 | PubMed |
| 25925871 | A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold. | Daru | 2015 | https://conductscience.org/library/papers/25925871 | PubMed |
| 25375834 | Exploration of the zinc finger motif in controlling activity of matrix metalloproteinases. | J Phys Chem B | 2014 | https://conductscience.org/library/papers/25375834 | PubMed |
| 25273674 | Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy. | J Hum Genet | 2014 | https://conductscience.org/library/papers/25273674 | PubMed |
| 25050378 | Matrix metalloproteinases and their multiple roles in Alzheimer's disease. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25050378 | PubMed |
| 25032844 | Alzheimer's disease--a panorama glimpse. | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/25032844 | PubMed |
| 23913860 | Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain. | FASEB J | 2013 | https://conductscience.org/library/papers/23913860 | PubMed |
| 23894097 | Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors. | ChemMedChem | 2013 | https://conductscience.org/library/papers/23894097 | PubMed |
| 23395821 | Molecular design of a highly selective and strong protein inhibitor against matrix metalloproteinase-2 (MMP-2). | J Biol Chem | 2013 | https://conductscience.org/library/papers/23395821 | PubMed |
| 23224743 | Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases. | J Comput Aided Mol Des | 2012 | https://conductscience.org/library/papers/23224743 | PubMed |
| 23201642 | Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities. | Molecules | 2012 | https://conductscience.org/library/papers/23201642 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MMP2 | 4313 | Swiss-Prot's references | https://conductscience.org/library/genes/4313 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21813640
GET https://conductscience.org/api/papers/v1/21813640/references?page=2